On September 4, the first batch of medical and health enterprises in Sichuan Province was held in Chengdu. At the meeting, relevant officials from the Provincial Science and Technology Department presented the “Sichuan Medical and Health Science and Technology Innovation Enterprise Joint Special Implementation Plan”, and the first batch of 12 enterprises signed a financial donation agreement. The reporter learned that the “Sichuan Pharmaceutical and Health Science and Technology Innovation Enterprise Joint Special Implementation Plan” focuses on major scientific and technical issues in the fields of health, life science, and biomedicine, and carries out innovative/generic drug research and clinical research, high-end medical devices and equipment research, and early disease screening and health management research. Through this model, we strive to break through a number of key core technologies, form a batch of innovative achievements and products with independent intellectual property rights, cultivate a group of highly innovative clinical research talents, create a number of demonstration application scenarios and technical application models, and formulate a number of diagnosis and treatment guidelines, expert consensus and industry standards. The relevant person in charge of the Provincial Science and Technology Department explained that the total amount of this special fund is estimated to be 57.6 million yuan/year, all of which are targeted charitable donations for enterprises. Funds are received and managed by the Sichuan Science and Technology Innovation Foundation, and the use, disbursement, and balance disposal of funds are independently managed by the foundation in accordance with the law. Special projects are divided into three categories: among them, major projects are 500,000 yuan/project, accounting for no less than 40% of the company's annual investment; 200,000 yuan/unit for key projects; and 100,000 yuan/project. The implementation cycle is from 2026 to 2028. Within a 3-year cycle, it can be adjusted flexibly according to the implementation situation.

Zhitongcaijing · 2d ago
On September 4, the first batch of medical and health enterprises in Sichuan Province was held in Chengdu. At the meeting, relevant officials from the Provincial Science and Technology Department presented the “Sichuan Medical and Health Science and Technology Innovation Enterprise Joint Special Implementation Plan”, and the first batch of 12 enterprises signed a financial donation agreement. The reporter learned that the “Sichuan Pharmaceutical and Health Science and Technology Innovation Enterprise Joint Special Implementation Plan” focuses on major scientific and technical issues in the fields of health, life science, and biomedicine, and carries out innovative/generic drug research and clinical research, high-end medical devices and equipment research, and early disease screening and health management research. Through this model, we strive to break through a number of key core technologies, form a batch of innovative achievements and products with independent intellectual property rights, cultivate a group of highly innovative clinical research talents, create a number of demonstration application scenarios and technical application models, and formulate a number of diagnosis and treatment guidelines, expert consensus and industry standards. The relevant person in charge of the Provincial Science and Technology Department explained that the total amount of this special fund is estimated to be 57.6 million yuan/year, all of which are targeted charitable donations for enterprises. Funds are received and managed by the Sichuan Science and Technology Innovation Foundation, and the use, disbursement, and balance disposal of funds are independently managed by the foundation in accordance with the law. Special projects are divided into three categories: among them, major projects are 500,000 yuan/project, accounting for no less than 40% of the company's annual investment; 200,000 yuan/unit for key projects; and 100,000 yuan/project. The implementation cycle is from 2026 to 2028. Within a 3-year cycle, it can be adjusted flexibly according to the implementation situation.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.